FCRL2 and B-cell chronic lymphocytic leukemia: Quantitative analysis revealed significantly elevated FcRL2 mRNA levels in B-CLL patient-derived peripheral blood mononuclear cells (PBMCs) compared to healthy controls (1.35–210-fold up-regulation, p < 0.0001).